A
$ Value
$0
Shares
44,834
Price
$0
Filed
Mar 5
Insider
Name
Glessner Coleen
Title
EVP, Quality & Ethics, and CPL
CIK
0001919170
Roles
Officer
Transaction Details
Transaction Date
2026-03-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
294,447
Footnotes
Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units | Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Filing Info
Glessner Coleen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | EBS | F | $69K |
| 2026-03-03 | EBS | A | $0 |
| 2026-03-01 | EBS | F | $3K |
| 2026-02-06 | EBS | D | $315K |
| 2026-02-06 | EBS | F | $31K |
| 2025-10-07 | EBS | ▼ | $306K |
| 2025-06-08 | EBS | F | $8K |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |